(Q73515406)
Statements
Recombinant mistletoe lectin (rML) is successful in treating human ovarian cancer cells transplanted into severe combined immunodeficient (SCID) mice (English)
U Schumacher
S Feldhaus
scientific article published on 01 March 2000